Europe Biotherapeutics Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Biotherapeutics Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Transfection Market Performance (Volume)
  • 2.1.2 Single Cell Cloning: Manual Limited Dilution Cloning, FACS, ClonePix and Others Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Transfection Market Performance (Value)
  • 2.1.2 Single Cell Cloning: Manual Limited Dilution Cloning, FACS, ClonePix and Others Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Clinical Treatment Market Performance (Volume)
  • 3.1.2 Scientific Research Market Performance (Volume)
  • 3.1.3 Other Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Beckman Coulter
  • 4.1.1 Beckman Coulter Profiles
  • 4.1.2 Beckman Coulter Product Information
  • 4.1.3 Beckman Coulter Biotherapeutics Business Performance
  • 4.1.4 Beckman Coulter Biotherapeutics Business Development and Market Status
• 4.2 Boehringer Ingelheim Pharma
  • 4.2.1 Boehringer Ingelheim Pharma Profiles
  • 4.2.2 Boehringer Ingelheim Pharma Product Information
  • 4.2.3 Boehringer Ingelheim Pharma Biotherapeutics Business Performance
  • 4.2.4 Boehringer Ingelheim Pharma Biotherapeutics Business Development and Market Status
• 4.3 CMC Biologics
  • 4.3.1 CMC Biologics Profiles
  • 4.3.2 CMC Biologics Product Information
  • 4.3.3 CMC Biologics Biotherapeutics Business Performance
  • 4.3.4 CMC Biologics Biotherapeutics Business Development and Market Status
• 4.4 Lonza Group
  • 4.4.1 Lonza Group Profiles
  • 4.4.2 Lonza Group Product Information
  • 4.4.3 Lonza Group Biotherapeutics Business Performance
  • 4.4.4 Lonza Group Biotherapeutics Business Development and Market Status
• 4.5 Partec
  • 4.5.1 Partec Profiles
  • 4.5.2 Partec Product Information
  • 4.5.3 Partec Biotherapeutics Business Performance
  • 4.5.4 Partec Biotherapeutics Business Development and Market Status
• 4.6 ProBioGen
  • 4.6.1 ProBioGen Profiles
  • 4.6.2 ProBioGen Product Information
  • 4.6.3 ProBioGen Biotherapeutics Business Performance
  • 4.6.4 ProBioGen Biotherapeutics Business Development and Market Status
• 4.7 SAFC
  • 4.7.1 SAFC Profiles
  • 4.7.2 SAFC Product Information
  • 4.7.3 SAFC Biotherapeutics Business Performance
  • 4.7.4 SAFC Biotherapeutics Business Development and Market Status
• 4.8 Selexis
  • 4.8.1 Selexis Profiles
  • 4.8.2 Selexis Product Information
  • 4.8.3 Selexis Biotherapeutics Business Performance
  • 4.8.4 Selexis Biotherapeutics Business Development and Market Status
• 4.9 Thermo Fisher Scientific
  • 4.9.1 Thermo Fisher Scientific Profiles
  • 4.9.2 Thermo Fisher Scientific Product Information
  • 4.9.3 Thermo Fisher Scientific Biotherapeutics Business Performance
  • 4.9.4 Thermo Fisher Scientific Biotherapeutics Business Development and Market Status

5 Market Performance for Manufacturers

• 5.1 Europe Biotherapeutics Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Europe Biotherapeutics Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Europe Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Europe Biotherapeutics Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Germany Market Performance for Manufacturers
  • 6.1.1 Germany Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Germany Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Germany Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Germany Biotherapeutics Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 UK Market Performance for Manufacturers
  • 6.2.1 UK Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 UK Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 UK Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 UK Biotherapeutics Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 France Market Performance for Manufacturers
  • 6.3.1 France Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 France Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 France Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 France Biotherapeutics Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Russia Market Performance for Manufacturers
  • 6.4.1 Russia Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Russia Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Russia Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Russia Biotherapeutics Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Benelux Market Performance for Manufacturers
  • 6.5.1 Benelux Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Benelux Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Benelux Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Benelux Biotherapeutics Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Italy Market Performance for Manufacturers
  • 6.6.1 Italy Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Italy Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Italy Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Italy Biotherapeutics Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Spain Market Performance for Manufacturers
  • 6.7.1 Spain Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Spain Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Spain Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Spain Biotherapeutics Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Biotherapeutics Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Biotherapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Biotherapeutics Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Biotherapeutics Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Europe Biotherapeutics Market Performance (Sales Point)

• 7.1 Europe Biotherapeutics Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Europe Biotherapeutics Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Europe Biotherapeutics Price (USD/Unit) by Regions 2013-2018
• 7.4 Europe Biotherapeutics Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Europe Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Germany Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 UK Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 France Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Russia Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Benelux Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Italy Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Biotherapeutics Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Clinical Treatment Industry
• 11.2 Scientific Research Industry
• 11.3 Other Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Europe Biotherapeutics Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Europe Biotherapeutics Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Germany Biotherapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 UK Biotherapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 France Biotherapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Russia Biotherapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Benelux Biotherapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Italy Biotherapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Spain Biotherapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Transfection Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Single Cell Cloning: Manual Limited Dilution Cloning, FACS, ClonePix and Others Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Clinical Treatment Sales and and Growth Rate 2019-2024
  • 12.4.3 Scientific Research Sales and and Growth Rate 2019-2024
  • 12.4.4 Other Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Europe Biotherapeutics Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Europe Biotherapeutics Gross Profit Trend 2019-2024

13 Conclusion